Trials / Unknown
UnknownNCT03962387
Evalution the Safety and Efficacy in Atopic Dermatitis Patients
A Multi-center, Open, Long-term Follow-up Study to Evaluate the Efficacy and Safety of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis: 5-year Results From the K0102 Extension Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 98 (actual)
- Sponsor
- Kang Stem Biotech Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, open, long-term follow-up study to evaluate the efficacy and safety of FURESTEM-AD inj. in patients with moderate to severe chronic atopic dermatitis: 5-year results from the K0102 extension study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Not applicable(observational study) | Not applicable(observational study) |
Timeline
- Start date
- 2019-04-05
- Primary completion
- 2024-01-02
- Completion
- 2024-01-02
- First posted
- 2019-05-24
- Last updated
- 2021-06-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03962387. Inclusion in this directory is not an endorsement.